Janux Therapeutics, Inc. (JANX)
15.82
+0.63
(+4.15%)
USD |
NASDAQ |
Apr 17, 16:00
15.82
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics SG&A Expense (Quarterly) : 10.85M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 2.181B |
| EyePoint, Inc. | 11.38M |
| CorMedix, Inc. | 39.58M |
| ADMA Biologics, Inc. | 24.64M |
| Viking Therapeutics, Inc. | 11.28M |